GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Capex-to-Operating-Income

Nuvation Bio (Nuvation Bio) Capex-to-Operating-Income : 0.00 (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Nuvation Bio's Capital Expenditure for the three months ended in Sep. 2021 was $-0.03 Mil. Its Operating Income for the three months ended in Sep. 2021 was $-22.79 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Nuvation Bio Capex-to-Operating-Income Historical Data

The historical data trend for Nuvation Bio's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Capex-to-Operating-Income Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Capex-to-Operating-Income
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Capex-to-Operating-Income Get a 7-Day Free Trial - - - - -

Competitive Comparison of Nuvation Bio's Capex-to-Operating-Income

For the Biotechnology subindustry, Nuvation Bio's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Capex-to-Operating-Income falls into.



Nuvation Bio Capex-to-Operating-Income Calculation

Nuvation Bio's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2020 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 0
=N/A

Nuvation Bio's Capex-to-Operating-Income for the quarter that ended in Sep. 2021 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.029) / -22.791
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Nuvation Bio Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.